Therapeutic Immunity by Adoptive Tumor-primed CD4(+) T-cell Transfer in Combination With In Vivo GITR Ligation

Similar Items

• Potent Tumor-Specific Protection Ignited by Adoptively Transferred CD4(+) T Cells
  od: Liu, Zuqiang, i dr.
  Izdano: (2008)
• Genetic Targeting of the Active Transcription Factor XBP1s to Dendritic Cells Potentiates Vaccine-induced Prophylactic and Therapeutic Antitumor Immunity
  od: Tian, Shenghe, i dr.
  Izdano: (2012)
• Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4(+) T cells combined with agonist α-GITR mAb promotes durable CD8(+) T-cell-dependent antitumor immunity
  od: Liu, Zuqiang, i dr.
  Izdano: (2017)
• Genetic Vaccines to Potentiate the Effective CD103(+)DC-mediated Cross-priming of Anti-tumor Immunity
  od: Zhang, Yi, i dr.
  Izdano: (2015)
• Knockdown of High Mobility Group Box 1 in Tumor Cells Attenuates Their Ability to Induce Regulatory T Cells and Uncovers Naturally Acquired CD8 T Cell-dependent Antitumor Immunity
  od: Liu, Zuqiang, i dr.
  Izdano: (2011)